Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
Portfolio Pulse from
Eli Lilly's stock dropped due to its 2024 revenue forecast falling short of expectations, impacting other companies in the GLP-1 diet drug market.
January 14, 2025 | 5:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Eli Lilly's stock fell by 7.38% after the company released a 2024 revenue forecast that was below Wall Street expectations, despite a positive 2025 outlook.
Eli Lilly's stock price is directly impacted by its revenue forecast. The 2024 forecast was below expectations, leading to a significant drop in stock price.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100